ISTH/LinkedIn
May 19, 2026, 15:57
Explore the Emerging Science Behind Factor XI/XIa Inhibition on the ISTH Academy – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“What if stroke prevention didn’t have to come with the same level of bleeding risk?
Explore the emerging science behind factor XI/XIa inhibition in this new learning resource on the ISTH Academy.
Review the role of FXI in thrombosis and hemostasis, examine key clinical trial data and discover how these therapies may reshape secondary stroke prevention.
- Includes real-world clinical scenarios
- CME credit available upon completion
Start learning today with the ISTH Academy.”
Other posts featuring International Society on Thrombosis and Haemostasis on Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability